bioRxivCancer Biology
Dual Energy X-ray Absorptiometry (DEXA) as a Longitudinal Outcome Measure of Cancer-Related Muscle Wasting in Mice
C. L. Cole, D. Robinson, J. Ye, B. Mills, S. A. Gerber, C. A. Beck, E. M. Schwarz, D. Linehan
Abstract
IntroductionPancreatic ductal adenocarcinoma (PDAC) is notorious for its associated skeletal muscle wasting (SMW) and mortality. Currently, the relationships between PDAC, SMW, and survival are poorly understood. Thus, there is a great need for a faithful small animal model with a quantitative longitudinal outcome measure that recapitulates clinical PDAC, to define SMW onset and assess progression. Therefore, we aimed to validate dual energy X-ray absorptiometry (DEXA) as a longitudinal outcome of lean body mass, and demonstrate its utility to quantify SMW in the KCKO murine model of PDAC. MethodsIn vivo body composition of: 1) untreated mice at 5, 8, 12, 18, and 22 weeks of age (n=4), and 2) a cohort of mice with (n=20) and without PDAC (n=10), was determined via DEXA, and lean mass of the lower hind limbs was predicted via a region of interest analysis by two independent observers. Total body weight was determined. Tibialis anterior (TA) muscles were weighed and processed for histomorphometry immediately post-mortem. Statistical differences between groups were assessed using t-tests and ANOVA. Linear regression models and correlation analysis were used to measure the association between TA and DEXA mass, and reproducibility of DEXA was quantified via the intraclass correlation coefficient (ICC). ResultsLean mass in growing untreated mice determined by DEXA correlated with TA mass (r2 = 0.94; p <0.0001) and body weight (r2 = 0.89; p <0.0001). DEXA measurements were highly reproducible between observers (ICC = 0.95; 95% CI: 0.89-0.98). DEXA and TA mass also correlated in the PDAC cohort (r2 = 0.76; p <0.0001). Significant SMW in tumor-bearing mice was detected within 38 days of implantation by DEXA, TA mass, and histomorphometry. ConclusionsDEXA is a longitudinal outcome measure of lower limb lean mass in mice. The KCKO syngeneic model is a bona fide model of PDAC-associated SMW that can be quantified with longitudinal DEXA.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Validation of Dual Energy X-ray Absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma
Z. R. Sechrist, G. Lee, … C. L. Cole·bioRxiv·Sep 17, 2023
- MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexia
Katherine R. Pelz, Philip Jimenez, … Teresa A. Zimmers·Cancer Research CommunicationsPeer-reviewed·Nov 24, 2025
- Sex-specific survival but not tissue wasting in the KPP mouse model of pancreatic cancer-induced cachexia
Natalia M. Weinzierl, Jayarani Fatimah Putri, … Erin E. Talbert·Journal of Applied PhysiologyPeer-reviewed·Sep 30, 2025
- Voluntary wheel running selectively preserves skeletal muscle during pancreatic cancer cachexia despite persistent systemic alterations
Cindy Richard, Arthur Dieumegard, … Amélie Rébillard·bioRxiv·Oct 20, 2026
- Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model
T. Gicquel, F. Marchiano, … A. Carrier·bioRxiv·Dec 28, 2022
- Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting
Yetiş Gültekin, Sharanya Sivanand, … Matthew G. Vander Heiden·bioRxiv·Mar 1, 2026